Reviews
Summary
Positives
- A 24-year-old with chronic inflammation since infancy described his fatigue, brain fog, and inflammatory symptoms easing within hours of starting a GLP-1 agonist Health Rising.
- A patient on Saxenda described self-injection as relatively painless and stress-free, with the small needle barely noticeable once the routine became familiar WebMD.
Negatives
- Liraglutide users reported asthenia, fatigue, malaise, dysgeusia, and dizziness within the first 12 weeks, often paired with nausea and vomiting FDA.
- A patient on Saxenda developed stomach pain and gallbladder symptoms severe enough to need pain management before discontinuing WebMD.
Hurdles & Side Effects
- A daily injection schedule and a side-effect burden heavier than newer weekly GLP-1s pushed many patients to ask about switching after a few months Health Rising.
- Patients without diabetes or a BMI qualifying for Saxenda struggled with insurance denials and had to pay out of pocket for a long-term off-label trial Mayo Clinic.
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care